4.6 Article

CLEFMA Induces the Apoptosis of Oral Squamous Carcinoma Cells through the Regulation of the P38/HO-1 Signalling Pathway

Journal

CANCERS
Volume 14, Issue 22, Pages -

Publisher

MDPI
DOI: 10.3390/cancers14225519

Keywords

CLEFMA; p38; HO-1; apoptosis; oral squamous carcinoma

Categories

Funding

  1. Ministry of Science and Technology, Taiwan [MOST-108-2314-B-040-010-MY3]

Ask authors/readers for more resources

This study demonstrates that CLEFMA induces apoptosis in oral squamous cell carcinoma (OSCC) through the activation of a p38-dependent HO-1 signaling cascade.
Simple Summary Oral squamous cell carcinoma (OSCC) constitutes more than 90% of head and neck cancers and a high prevalence rate in some parts of the world. Alcohol consumption, use of snuff, and several other factors including genetic makeup are associated with 90% of patients with oral cancer. However, the molecular mechanisms involved in CLEFMA-mediated apoptotic cell death of human OSCC remain poorly understood. Our study found that CLEFMA induced the heme oxygenase-1 (HO-1) level by activating p38 mitogen-activated protein kinase signalling cascade and subsequently activated caspase-dependent cell death, which is critical to the anti-cancer effect in OSCC. The purpose of this research was to evaluate the impact and the underlying molecular mechanism of CLEFMA-induced cell death in human OSCC. The anti-tumour properties of CLEFMA in oral cancer were explored using colony formation, flow cytometry, human apoptosis array, Western blot, and immunohistochemistry assays. The in vivo anti-tumour effect of CLEFMA administered by oral gavage was evaluated using SCC-9-derived xenograft-bearing nude mouse models. CLEFMA significantly suppressed colony formation and elicited cellular apoptosis in oral cancer cells. CLEFMA treatment remarkably increased phosphorylated p38 and HO-1 along with cleavage of poly ADP-ribose polymerase and activation of caspase-8, -9, and -3 in HSC-3 and SCC-9 cells. Administration of HO-1 small interfering RNA significantly protected the cells from CLEFMA-induced caspase-3, -8, and -9 activation. Attenuation of p38 activity by the pharmacologic inhibitor SB203580 dramatically reduced CLEFMA-induced caspase-3, -8, and -9 activation and HO-1 expression in OSCC. The subcutaneous murine xenograft models showed that CLEFMA in vivo suppressed tumour growth in implanted SCC-9 cells. All of these findings indicated that CLEFMA induced apoptosis through the p38-dependent rise in HO-1 signal transduction cascades in OSCC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available